#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3297474	B	Binding affinity to human RXR-alpha-ligand binding domain homodimers by fluorescence quenching method	Homo sapiens	8	ALA3286246	single protein format	Scientific Literature
2.	ALA3297475	B	Agonist activity at Gal4-fused human RXR-alpha expressed in HEK293 cells assessed as receptor-mediated transcriptional activity treated 24 hrs after transfection measured 48 hrs post-transfection by dual luciferase reporter assay	Homo sapiens	8	ALA3286246	cell-based format	Scientific Literature
3.	ALA3297476	B	Agonist activity at Gal4-fused human RAR-alpha expressed in HEK293 cells assessed as receptor-mediated transcriptional activity at 1 uM treated 24 hrs after transfection measured 48 hrs post-transfection by dual luciferase reporter assay	Homo sapiens	5	ALA3286246	cell-based format	Scientific Literature
4.	ALA3297477	B	Agonist activity at human RXR-alpha-ligand binding domain homodimers assessed as coactivator recruitment by measuring GRIP1 binding to receptor by isothermal titration calorimetry	Homo sapiens	8	ALA3286246	single protein format	Scientific Literature
5.	ALA3297478	B	Agonist activity at RXR-alpha in rat R3KE cells infected with oncogene KLF4-ER assessed as inhibition of KLF4-mediated oncogenic transformation	Rattus norvegicus	8	ALA3286246	cell-based format	Scientific Literature
6.	ALA3297480	A	Induction of hyperlipidemia in N-methylnitrosurea-induced mammary cancer Sprague-Dawley rat model assessed as increase in serum triglyceride level at 200 mg/kg administered through diet for 7 days	Rattus norvegicus	6	ALA3286246	organism-based format	Scientific Literature
7.	ALA3297482	F	Anticancer activity against N-methylnitrosurea-induced mammary cancer in Sprague-Dawley rat assessed as decrease in proliferation index at 200 mg/kg administered through diet for 7 days by BrdU incorporation assay	Rattus norvegicus	6	ALA3286246	organism-based format	Scientific Literature
8.	ALA3297483	T	Toxicity in N-methylnitrosurea-induced mammary cancer Sprague-Dawley rat model assessed as body weight at 200 mg/kg administered through diet for 7 days	Rattus norvegicus	4	ALA3286246	organism-based format	Scientific Literature
9.	ALA3297484	T	Toxicity in N-methylnitrosurea-induced mammary cancer Sprague-Dawley rat model assessed as liver weight at 200 mg/kg administered through diet for 7 days	Rattus norvegicus	4	ALA3286246	organism-based format	Scientific Literature
10.	ALA3626726	B	Agonist activity at human RXRalpha LBD expressed in HEK293 cells transfected with Gal4 reporter assessed as increase of transcription at 10'-6 M by dual luciferase reporter assay relative to control	Homo sapiens	10	ALA3621048	cell-based format	Scientific Literature
11.	ALA3626727	F	Anticancer activity in methylnitrosourea-induced mammary cancer model of Sprague-Dawley rat assessed as reduction of cancer number at 200 mg/kg treated with diet for 3 months relative to control	Rattus norvegicus	9	ALA3621048	organism-based format	Scientific Literature
12.	ALA3626728	F	Anticancer activity in methylnitrosourea-induced mammary cancer model of Sprague-Dawley rat assessed as reduction of cancer weight at 200 mg/kg treated with diet for 3 months relative to control	Rattus norvegicus	12	ALA3621048	organism-based format	Scientific Literature
13.	ALA3626737	A	Metabolic stability in methylnitrosourea-induced mammary cancer model of Sprague-Dawley rat assessed as compound level in serum at 200 mg/kg treated with diet for 3 months	Rattus norvegicus	7	ALA3621048	organism-based format	Scientific Literature